Latest Europe News

Clever Culture Systems has doubled its large pharmaceutical customer base to eight, installed 34 APAS Independence instruments, and expects FY27 sales growth driven by existing and new customers. The company maintains a $1.7 million cash balance, raised $1.6 million in short-term debt, and is expanding validation services.

BLS Pharmaceuticals capped FY2026 with record quarterly revenue and operating cash flow, driven by international expansion and new supply agreements across regulated markets.

OncoSil Medical reported a 53% increase in unit sales and advanced key regulatory approvals, including FDA final review and TGA listing, positioning it for growth in pancreatic cancer treatment.

Nordic Resources (ASX:NNL) has reported final assays from its 1H 2026 drilling in Finland, revealing record gold grades at Kopsa and significant resource extensions across its key gold projects. Metallurgical testing is underway, with updated resource estimates expected later this year.

Berkeley Energia has reported a maiden inferred lithium and rubidium resource at its Conchas Project in Spain, alongside appointing former Endesa CEO José Bogas Gálvez to its board, while continuing a US$1.25 billion arbitration against Spain over its Salamanca uranium project.

Streamplay Studio Limited has reported its fifth straight quarter of positive operating cash flow, driven by strong customer receipts and strategic publishing deals. The company is advancing multiple game releases and expanding its cloud gaming footprint across new regions.

Tungsten Mining has locked in a robust economic case for its Watershed project with a pre-tax NPV of A$1.31 billion and IRR near 200%, while launching its largest-ever drilling campaign at Mt Mulgine to underpin long-term growth.

RooLife Group (ASX:RLG) is expanding its renewable energy footprint by acquiring a battery storage and microgrid business and raising $1.06 million in a placement to fund growth and project delivery.

Nodestream has advanced its defence strategy with key leadership hires, a $6.5 million capital raise, and fresh product launches, while expanding its footprint in the US and European markets.

Cyclopharm’s Technegas® has been named the preferred ventilation agent in new US lung imaging guidelines, marking the first update in 14 years and potentially accelerating adoption across American hospitals.

Saluda Medical capped FY26 with a 28% revenue surge, beating guidance at US$90.2 million, while FDA approval for its CAP24 paddle lead opens a new US surgical market segment.

Carnegie Clean Energy has made substantial progress on its ACHIEVE Programme, including module assembly and regulatory approvals for ocean deployment in Spain, supported by a $2.5 million private placement to fund commercial expansion.